International Journal of Stroke/journals.sagepub.com
Jul 31, 2026, 16:37
No Clear Benefit of Short-Term Dual Antiplatelet Therapy in TIA or Stroke Without ≥50% Stenosis – International Journal of Stroke
International Journal of Stroke shared a post on LinkedIn about a recent article by Mateus Kist Ibiapino et al., adding:
”New meta-analysis
In patients with TIA or ischemic stroke without at least 50 percent large-artery stenosis, the benefit of short-term dual antiplatelet therapy is uncertain and may come with a higher bleeding risk.”
Title: Dual Antiplatelet Therapy in Stroke Without Stenotic Atherosclerosis: A Meta-Analysis with Trial Sequential Analysis
Authors: Mateus Kist Ibiapino, Marwa Ibrahim, Vanisha Kumar, Diana Lissie Mamani-Sucari, Sofia Zuppi Sardinha Mantovani, Igor Haitovich, Leonardo Caetano Borgomanero, Gisele Sampaio Silva

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian